Overexpression of Rictor protein and Rictor-H. pylori interaction has impact on tumor progression and prognosis in patients with gastric cancer

• Autorzy: Wang F. , Lou X. , Zou Y. , Hu D. , Liu J. , Ning J. , Jiao Y. , Zhang Z. , Yang F. , Fan L. , Yu H. , Wei W. , Wang H. , Sun G.
• Języki publikacji: EN

Abstrakty

EN

Słowa kluczowe

EN

rapamycin; gastric cancer; Helicobacter pylori; prognosis; siRNA; patient; immunohistochemistry

• Wydawca: -
• Czasopismo: Folia Histochemica et Cytobiologica
• Rocznik: 2020
• Tom: 58
• Numer: 2
• Opis fizyczny: p.96-107,fig.,ref.

Twórcy

autor

Wang F.

• Department of Oncology, the First Affiliated Hospital of Anhui Medical University, Hefei 230022, Anhui, China

autor

Lou X.

• Department of Oncology, the First Affiliated Hospital of Anhui Medical University, Hefei 230022, Anhui, China

autor

Zou Y.

• Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, Hefei 230032, Anhui, China

autor

Hu D.

• Department of Oncology, the First Affiliated Hospital of Anhui Medical University, Hefei 230022, Anhui, China

autor

Liu J.

• Department of Pharmacy, the First Affiliated Hospital of Anhui Medical University, Hefei 230022, Anhui, China

autor

Ning J.

• Department of Oncology, the First Affiliated Hospital of Anhui Medical University, Hefei 230022, Anhui, China

autor

Jiao Y.

• Department of Oncology, the First Affiliated Hospital of Anhui Medical University, Hefei 230022, Anhui, China

autor

Zhang Z.

• Department of Pathology, the First Affiliated Hospital of Anhui Medical University, Hefei 230022, Anhui, China

autor

Yang F.

• Department of Pathology, the First Affiliated Hospital of Anhui Medical University, Hefei 230022, Anhui, China

autor

Fan L.

• Department of Oncology, the First Affiliated Hospital of Anhui Medical University, Hefei 230022, Anhui, China

autor

Yu H.

• Department of Oncology, the First Affiliated Hospital of Anhui Medical University, Hefei 230022, Anhui, China

autor

Wei W.

• Institute of Clinical Pharmacology, Anhui Medical University, Hefei 230032, Anhui, China

autor

Wang H.

• Department of Oncology, the First Affiliated Hospital of Anhui Medical University, Hefei 230022, Anhui, China
• Institute for Liver Diseases of Anhui Medical University, Hefei 230032, Anhui, China

autor

Sun G.

• Department of Oncology, the First Affiliated Hospital of Anhui Medical University, Hefei 230022, Anhui, China

Identyfikatory

DOI

10.5603/FHC.a2020.0015